Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.
PubMed 36253442 ↗Tianeptine
Also known as Stablon
The short answer. More people than not who report on Tianeptine say it helped (63% of 155). It is most often used for mood: 95% of 148 reports say that improved. It is well studied — 18 meta-analyses on PubMed. The most common complaint is addiction.
From 322 mentions in total — the rest didn't say how it went and aren't counted.
What Tianeptine does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 18 meta-analyses on PubMed ↗ · 42 randomized trials ↗
Conclusion: Direct pooled evidence supports the efficacy and tolerability of methylphenidate or atomoxetine for treatment of ADHD symptoms in children and youth with ASD. The current review highlights the efficacy of standard ADHD pharmacotherapy for treatment of ADHD symptoms in children and youth with ASD. Consideration of the benefits weighed against the limitations of safety/efficacy data and lack of data evaluating long-term continuation is undertaken to help guide clinical decision-making regarding treatment of co-occurring ADHD symptoms in children and youth with ASD.
PubMed 32845025 ↗Conclusion: There is a paucity of data on suicidal ideation/behavior, but paroxetine may increase the risk of suicidality in the treatment of AD and venlafaxine for MDD. Findings from this review must be considered in light of potential limitations, such as the lack of comparative information about many antidepressants, the short-term outcomes and the quality of the available evidence.
PubMed 32982805 ↗Conclusion: Dose reduction in CKD3-5 is necessary for selegiline, amitriptylinoxide, venlafaxine, desvenlafaxine, milnacipran, bupropion, reboxetine and tianeptine. The evidence on effectiveness of antidepressants versus placebo in patients with CKD3-5, and with the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)-defined depression is insufficient, and in view of the high prevalence, a well-designed RCT is greatly needed.
PubMed 22859791 ↗9 human trials on ClinicalTrials.gov test Tianeptine — 5 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗
- The Efficacy of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery. · Post-mastectomy Pain Syndrome · 2025
- Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) · Depression, Depressive Disorder · 2023
- Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea · Major Depression · 2022
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
52 reports name a product containing Tianeptine (2015–2025); 39 involved hospitalization or worse. Most often reported:
- Dependence · 17
- Death · 9
- Withdrawal syndrome · 7
- Anxiety · 6
- Overdose · 6
- Loss of consciousness · 6
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Not a scheduled substance, but the DEA lists Tianeptine as a drug of concern. DEA fact sheet ↗
The FDA found Tianeptine as an undeclared ingredient in 2 products sold as supplements, most recently on 2026-01-09. FDA tainted-products database ↗
NIH has funded 1 research project with Tianeptine in the title, $78,599 in total (2022–2023). NIH RePORTER ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“It has really improved the quality of my life, more than anything else I have taken.”
“tianeptine for example. It has done wonders for my anxiety like no other compound. Now I have to choose between remission of anxiety or buying from some rando lab in China because people ODed on it.”
“I take 15mg 3x daily, and it keeps me out of depression and in a good mood. It also helps me focus in class more.”
“Tianeptine works as a powerful anti-depressant for me and many others at small dosages (~12.5mg).”
Top discussions (5)
Tianeptine compared
Other options for mood
Sources
- User reports: 322 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA tainted-products database ↗
- US DEA ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate